Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
take every 4 to 6 hours do not take more than 6 doses in 24 hours Age Dose adults and children 12 years and over 1 to 2 capsules children 6 to under 12 years of age 1 capsule children under 6 years of age do not use this product in children under 6 years of age
store at temperature 15° to 30° C (59° to 86°F) do not use if either capsule band or imprinted safety seal under cap is broken or missing protect from moisture
Diphenhydramine Hydrochloride 50 mg
Antihistamine
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| Age | Dose |
| adults and children 12 years and over | 1 to 2 capsules |
| children 6 to under 12 years of age | 1 capsule |
| children under 6 years of age | do not use this product in children under 6 years of age |
colloidal silicon dioxide, croscarmellose sodium, hard gelatin capsules, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline
cellulose, propyl paraben sodium.
Call toll-free 1-877-225-6999
Mfg Lic .No: TN/DRUGS/558/1997
Manufactured for:
Akron Pharma, Inc,
373 RT US 46 W, Building E,
Suite 117, Fairfield, NJ 07004
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71399-8026-1 | 2025-01-30 | C162847 | 48780-1 | f386c64a-30a2-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8026-2 | 2025-01-30 | C162847 | 48780-1 | f386c64a-30a2-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8026-1 | 2023-02-28 | C162847 | 48780-1 | f386c64a-30a2-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8026-2 | 2023-02-28 | C162847 | 48780-1 | f386c64a-30a2-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8026-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-30a2-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8026-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-30a2-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71399-8026-1 | Diphenhydramine HCl | 100 in 1 BOTTLE | CAPSULE | 100 | 5 | |
| 71399-8026-2 | Diphenhydramine HCl | 1000 in 1 BOTTLE | CAPSULE | 1000 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71399-8026 | DIPHENHYDRAMINE HCL CAPSULE [AKRON PHARMA INC.] | 5 | Legacy NDC, 2 package rows | 20230302_aa8e72b9-ae59-4563-b3c7-9d48d0cc2c52.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71399-8026-2 | EA - Each | 71399-8026 | d16da9fa-45f5-4c6e-aa6c-fbdf54ab10c9 | 1 | 2021-08-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71399-8026 | 71399-8026-1, 71399-8026-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | TC2D6JAD40 | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| GELATIN | 2G86QN327L | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| PROPYLPARABEN SODIUM | 625NNB0G9N | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d89d316b-1d9b-451d-9502-a90a92e5b9bb | aa8e72b9-ae59-4563-b3c7-9d48d0cc2c52 | 2023-02-26 | Warnings | d89d316b-1d9b-451d-9502-a90a92e5b9bb aa8e72b9-ae59-4563-b3c7-9d48d0cc2c52 |
Adverse event summaries are temporarily unavailable. Other product information remains available.